F S&P 500
5,209.25 -3.50 (-0.07%) F Dow Jones
39,179.00 -16.00 (-0.04%) F Nasdaq
18,162.25 -24.25 (-0.13%) E-mini Russell 2000 Index Futur
2,061.30 -3.50 (-0.17%) Petróleo
79.36 +0.37 (+0.47%) Oro
2,316.70 -5.60 (-0.24%)
Cibus, Inc. (CBUS)
Cibus, Inc.
6455 Nancy Ridge Drive
San Diego, CA 92121
United States
858 450 0008
https://www.cibus.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo: 183
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Rory Balfour Riggs M.B.A. | Co-Founder, CEO & Chairman | 292.31k | N/D | 1953 |
| Dr. Peter Beetham B.Sc., Ph.D. | Co-Founder, President, COO & Director | 292.31k | N/D | 1963 |
| Dr. Greg Gocal Ph.D. | Co-Founder, Chief Scientific Officer & Executive VP | 266.01k | N/D | 1969 |
| Dr. Wade Hampton King | Chief Financial Officer | N/D | N/D | 1957 |
| Mr. Jason Stokes J.D. | Chief Legal Officer, General Counsel & Corporate Secretary | N/D | N/D | N/D |
| Ms. Rosa Cheuk Kim J.D. | Senior Vice President of Legal | N/D | N/D | N/D |
| Dr. James Radtke Ph.D. | Senior Vice President of Product Development | N/D | N/D | N/D |
| Mr. Tony Moran | Senior Vice President of International Development | N/D | N/D | N/D |
| Norm Sissons | Senior Vice President of Seed & Traits | N/D | N/D | N/D |
| Ms. Noel Sauer Ph.D. | Senior Vice President of Research | N/D | N/D | N/D |
Descripción
Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.
Gestión corporativa
La calificación ISS Governance QuickScore de Cibus, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
